Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 13Recruiting 8Terminated 7Withdrawn 5Unknown 5Active not recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Sex Cord-Gonadal Stromal Tumors 1Neoplasms, Germ Cell and Embryonal 1Glioblastoma 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Quality of Life × Clear all
NCT03251027 2026-01-27

Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Thomas Jefferson University

Phase NA Active not recruiting
100 enrolled
CNS

Glioblastoma

NCT03418844 2025-09-22

VIVROVAIRE TR

Centre Francois Baclesse

Phase NA Active not recruiting
268 enrolled

Neoplasms, Germ Cell and Embryonal, Sex Cord-Gonadal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡